Publications

5600 Results

Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.

Authors
BGM Durie;J Crowley;C Coltman, Jr;RA Chapman;SP Balcerzak;JD Bonnet;DA Lipschitz;RL Stephens;BD Cheson
Journal / Conference
IND 9:329-331
Year
1991
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8108

Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.

Authors
CL Willman;CC Stewart;TL Longacre;DR Head;R Habbersett;SF Zeigler;RM Perlmutter
Journal / Conference
Blood 77(4):726-734
Year
1991
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8124/25/26, SWOG-8600

Chemotherapy in advanced ovarian cancer; an overview of randomized clinical trials. Advanced ovarian cancer trialists group.

Journal / Conference
British Medical Journal 303:884-893
Year
1991
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Long term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.

Authors
RI Fisher;DL Long;VT DeVita;SM Hubbard;TP Miller;RC Young
Journal / Conference
Ann Oncol 2(suppl.1):33-35
Year
1991
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8503

Development of surgical quality-control mechanisms in large scale prospective trials: Head & Neck Intergroup Report.

Authors
JR Jacobs;RF Pajak;E Weymuller;D Sessions;DE Schuller
Journal / Conference
Head and Neck 13(1):28-32
Year
1991
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Do otolarynologist-head and neck surgeons and/or chemotherapy have a role in the treatment of head and neck cancer?

Authors
DE Schuller
Journal / Conference
Otolaryngology-Head and Neck Surgery 117:498-501
Year
1991
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Alpha interferon for remission maintenance: Preliminary report on the Southwest Oncology Group study.

Authors
SE Salmon;J Beckord;RP Pugh;B Barlogie;J Crowley
Journal / Conference
Seminars in Oncology 18(5):33-36
Year
1991
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8624

A phase II multi-institutional trial of low dose PALA and high dose 5-FU as a short term infusion in the treatment of adenocarcinoma of the pancreas: A Southwest Oncology Group study.

Authors
LM Morrell;B Ardalan;SP Richman;P Goodman;TR Fleming;JS Macdonald
Journal / Conference
Cancer 67(2):363-366
Year
1991
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8729

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol.

Authors
CR Nichols;SD Williams;PJ Loehrer;FA Greco;ED Crawford;J Wettlaufer;ME Miller;A Bartolucci;L Schacter;LH Einhorn
Journal / Conference
JCO 9(7):1163-1172
Year
1991
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8788

New biologic markers in non-Hodgkin's lymphomas.

Authors
TM Grogan;TP Miller
Journal / Conference
Hematology/Oncology Clinics of North America 5(5):925-933
Year
1991
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819